Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,132 public trials 395 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy

NCT02028403

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Washington University Therapeutics (WT) CRS St Louis, Missouri, United States
  • Chapel Hill CRS Chapel Hill, North Carolina, United States
  • Cincinnati Clinical Research Site Cincinnati, Ohio, United States
View Trial Details
Completed

Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents

NCT00921557

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • David Geffen School of Medicine at UCLA NICHD CRS Los Angeles, California, United States
  • Pediatric Perinatal HIV Clinical Trials Unit CRS Miami, Florida, United States
  • USF - Tampa NICHD CRS Tampa, Florida, United States
  • Lurie Children's Hospital of Chicago (LCH) CRS Chicago, Illinois, United States
View Trial Details
Completed

An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy

NCT00004978

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +15 more
Locations
  • VA Greater Los Angeles Healthcare System, Infectious Diseases Section CRS Los Angeles, California, United States
  • Dr. M. Estes Med. Practice CRS Mill Valley, California, United States
  • Dr. Robert Scott Med. Practice CRS Oakland, California, United States
  • East Bay AIDS Ctr. CRS Oakland, California, United States
View all 248 locations
View Trial Details
Completed

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

NCT00039741

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Usc La Nichd Crs Alhambra, California, United States
  • Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach, California, United States
  • Children's Hospital of Los Angeles NICHD CRS Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
View all 31 locations
View Trial Details
Completed

Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women

NCT01494038

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations
  • Gaborone CRS Gaborone, Botswana
  • Molepolole CRS Gaborone, Botswana
  • Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS Port-au-Prince, Haiti
  • Byramjee Jeejeebhoy Medical College (BJMC) CRS Pune, Maharashtra, India
View all 13 locations
View Trial Details
Completed

Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection

NCT01780831

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Usc La Nichd Crs Los Angeles, California, United States
  • Children's National Med. Ctr. Washington DC NICHD CRS Washington D.C., District of Columbia, United States
  • Univ. of Florida Jacksonville NICHD CRS Jacksonville, Florida, United States
  • Rush Univ. Cook County Hosp. Chicago NICHD CRS Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

NCT00992017

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Usc La Nichd Crs Alhambra, California, United States
  • University of California, UC San Diego CRS La Jolla, California, United States
  • Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
View all 31 locations
View Trial Details
Completed

Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%

NCT02269163

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • University of California, Irvine Irvine, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Immunoe International Research Centennial, Colorado, United States
  • National Jewish Hospital Denver, Colorado, United States
View all 13 locations
View Trial Details
Completed

Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

NCT00016718

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UCSD Maternal, Child, and Adolescent HIV CRS San Diego, California, United States
  • UCSF Pediatric AIDS CRS San Francisco, California, United States
  • Univ. of Colorado Denver NICHD CRS Aurora, Colorado, United States
  • Howard Univ. Washington DC NICHD CRS Washington D.C., District of Columbia, United States
View all 18 locations
View Trial Details

Related conditions